Becton, Dickinson And Co. BDX

NYS: BDX | ISIN: US0758871091   22/10/2025
188,11 USD (-0,49%)
(-0,49%)   22/10/2025

20 oktober 2025 · BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings · Persbericht

16 oktober 2025 · BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region · Persbericht

15 oktober 2025 · BD Announces CFO Transition Plan · Persbericht

9 oktober 2025 · BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025 · Persbericht

9 oktober 2025 · BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease · Persbericht

8 oktober 2025 · BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation · Persbericht

3 oktober 2025 · BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C. · Persbericht

22 september 2025 · BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery · Persbericht

17 september 2025 · BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics · Persbericht

2 september 2025 · BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative · Persbericht

14 augustus 2025 · BD to Present at Wells Fargo 2025 Healthcare Conference · Persbericht

7 augustus 2025 · BD Reports Third Quarter Fiscal 2025 Financial Results · Persbericht

5 augustus 2025 · BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories · Persbericht

4 augustus 2025 · BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care · Persbericht

31 juli 2025 · BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home · Persbericht

30 juli 2025 · BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test · Persbericht

23 juli 2025 · BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs · Persbericht

22 juli 2025 · BD Board Declares Dividend · Persbericht

15 juli 2025 · Regroupement de Waters et de la division Biosciences & Diagnostic Solutions de BD, Création d'un leader des sciences de la vie et du diagnostic axé sur les tests réglementés à haut volume · Persbericht

15 juli 2025 · Bedrijfsnieuws uit Amerika · Bolero.be

Newmont vervangt CFO Karyn Ovelmen door Peter Wexler als interim-CFO. Het Amerikaanse goudmijnbedrijf kondigde aan dat CFO Karyn Ovelmen aftreedt en wordt vervangen door insider Peter Wexler als interim CFO, in afwachting...

Mijn selecties